info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0154788-01
Couldn't load pickup availability
Belizatinib (TSR-011) is an orally active, potent inhibitor of ALK and TRKA, TRKB, and TRKC, with IC50 of 0.7 nM for wild-type recombinant ALK kinase.
[1357920-84-3]
C33H44FN5O3
577.73
O=C(NC1=NC2=CC=C(CN3CCC(C(C)(O)C)CC3)C=C2N1[C@H]4CC[C@@H](C(NC(C)C)=O)CC4)C5=CC=C(F)C=C5
Anaplastic lymphoma kinase (ALK) ; Trk Receptor
TrkA; TrkB; TrkC
10mM
99.62
DMSO : ≥ 300 mg/mL
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
H302, H315, H319, H335
Loading...
Total items
Product subtotal
Belizatinib is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.